Article

Congressional briefing boosts collaborative effort

Congressional

A congressional briefing at the National Eye Institute has highlighted the need for research partnerships to fight diabetic retinopathy effectively.

The briefing featured Thomas W. Gardner, MD, MS, a diabetes researcher, clinician and professor of ophthalmology and cellular and molecular physiology from the Pennsylvania State University Milton S. Hershey Medical Center, part of the Diabetic Retinopathy Clinical Research (DRCR) Network.

During the one-day event, Dr. Gardner met with Rep. Gene Green (D-TX), a co-chairman of the Congressional Vision Caucus with NIH oversight, as well as senators Arlen Specter and Rick Santorum (both R-PA).

The network, funded by NEI and the Juvenile Diabetes Research Foundation International, is a collaboration of clinicians and researchers from different specialties who are combining their skills to discover preventions, treatments, and cures for diabetic retinopathy.

The network includes 545 experts at 163 clinical sites in 43 states and is one of several collaborative efforts funded by the NEI over the past 30 years to study diabetic retinopathy. These networks have led to effective diabetic retinopathy treatments that have reduced blindness by 90% and save $1.6 billion annually in health-care costs, the NEI said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
© 2025 MJH Life Sciences

All rights reserved.